Plain-English translation of NCT05251883 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →This research study is collecting tissue samples and medical information from women diagnosed with metastatic ovarian cancer—cancer that has spread beyond the ovaries. Researchers will analyze the genetic and molecular makeup of these samples to better understand how the disease develops and spreads, and to identify new targets for future treatments. The goal is to build a comprehensive database that combines genetic data, imaging results, and medical records to help predict how the disease will progress and respond to therapy.
More than 70% of ovarian cancers are discovered after they have already spread to other parts of the body, which makes them harder to treat. By studying the genetic and molecular characteristics of metastatic ovarian cancer in depth, researchers hope to uncover new ways to predict patient outcomes and develop more targeted, effective treatments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo ovarian cancer surgery and follow-up treatment as part of your regular care at the hospital. Researchers will collect tissue samples from your surgery and gather information from your medical records, imaging tests, and pathology reports. You will not need to make extra visits solely for research purposes—the sample collection happens during your standard surgical procedure. The study team will use this information to build a database and analyze patterns that may help future patients.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China